IN-DATE
S1.1530: FCI LacriJet Preloaded, Self-Retaining Monocanalicular Nasolacrimal Intubation 30mm
Sign in to add this product to your favorites!
| Price: | $15.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 1 box of 1 |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 8 hours 26 minutes and choose overnight shipping at checkout. |
Additional Details
FCI Ophthalmics LacriJet
LacriJet® is a preloaded & self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration. It consists of a single use injector handpiece into which a silicone tube is preloaded inside a metallic guide. LacriJet® has been specifically designed to reduce operating time, eitherin the intubation phase as well as forthe removal of the device. LacriJet® is first introduced into the nasolacrimal duct. Once in position, the sliding piston is retracted and the silicone intubation is released. It is maintained in place at the punctum by a plug-like fixation head: no nasal retrieval, no knots and no sutures are needed. The smaller sizes LacriJet® 15 mm and 20 mm have been specifically designed for canalicular laceration repair to prevent future canalicular obstruction due to scar tissue formation.
- Diameter: 0.64mm
- Material: Silicone
- Requires sizer (S1.1288) to select the length & 0.3mm disposable punctum dilator and plug inserter (S1.3090)
Features
- Silicone tube preloaded inside metallic guide
- No nasal retrieval
- No knots or sutures needed
- 3 mm plug collarette
- Sterile
FCI Lacrijet Product Options
- S1.1515: 15mm
- S1.1522: 22mm
- S1.1530: 30mm
- S1.1535: 35mm
- S1.1540: 40mm
- S1.1545: 45mm
- S1.1550: 50mm
Additional Details
- Company Name: FCI Ophthalmics
- FDA Product Code: OKS
- FDA Product Code Name: Lacrimal intubation set
- GMDN Term Code: 47929
- GMDN Term Name: Lacrimal Tube
- GMDN Term Definition: A collection of devices intended to be used to maintain patency of the nasolacrimal system typically for treating/preventing pathologies of the tear drainage system (e.g., post-chemotherapy stenosis) or after dacryocystorhinostomy (DCR). It consists of a long and flexible bicanalicular or monocanalicular tube (e.g., Crawford type) inserted through the lacrimal puncta into the canaliculi, lacrimal sac, and/or nasolacrimal duct; devices to assist the intubation procedure are typically provided preassembled to the tube (e.g., cannula, probes, bougies, introducer, stylet). The tube is typically left in place long-term before removal. This is a single-use device.
AccessGUDID Info
- FDA Product Code: OKS
- FDA Product Code Name: Lacrimal Stents And Intubation Sets
- GMDN Term Code: 47929
- GMDN Term Name: Lacrimal intubation set
- GMDN Term Description: A collection of devices intended to be used to maintain patency of the nasolacrimal system typically for treating/preventing pathologies of the tear drainage system (e.g., post-chemotherapy stenosis) or after dacryocystorhinostomy (DCR). It consists of a long and flexible bicanalicular or monocanalicular tube (e.g., Crawford type) inserted through the lacrimal puncta into the canaliculi, lacrimal sac, and/or nasolacrimal duct; devices to assist the intubation procedure are typically provided preassembled to the tube (e.g., cannula, probes, bougies, introducer, stylet). The tube is typically left in place long-term before removal. This is a single-use device.
Manufacturer
FCI Ophthalmics is a specialty medical device company focused on developing and supplying innovative surgical products for ophthalmology, particularly in the areas of oculoplastics, lacrimal surgery, and retina. The company offers a broad portfolio that includes lacrimal stents and intubation systems, orbital implants, eyelid weights, punctal plugs, and devices for retinal and vitreoretinal procedures. Known for products like the Monoka stent, the BIKA intubation system, and the TearStim dry eye treatment device, FCI supports ophthalmic surgeons with precise, minimally invasive solutions designed to restore function and improve patient comfort in both reconstructive and functional eye surgeries.
